Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2026-02-25 @ 11:05 PM
Study NCT ID:
NCT01964495
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2013-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
Sponsor:
Medical Center Alkmaar
Organization:
Study Overview
Official Title:
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REDUCE
Brief Summary:
The purpose of this study is to evaluate two different treatment strategies in patients admitted to hospital with Community Acquired Pneumonia. The investigators hypothesize treatment according to both procalcitonin (PCT) and C-reactive protein (CRP) will be effective in reducing the length of antibiotic treatment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: